| RS137852855 |
SUMF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS137852856 |
BBS9
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 9, Bardet-Biedl syndrome |
| RS137852857 |
BBS9
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 9 |
| RS137852858 |
BBS9
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 9, Bardet-Biedl syndrome |
| RS137852859 |
NHLRC1
|
Health Risk |
Pathogenic |
Myoclonic epilepsy of Lafora 2, Myoclonic epilepsy of Lafora 2 |
| RS137852860 |
SUGCT
|
Health Risk |
Conflicting classifications of pathogenicity |
Glutaryl-CoA oxidase deficiency, SUGCT-related disorder |
| RS137852861 |
SUGCT
|
Health Risk |
Pathogenic |
Glutaryl-CoA oxidase deficiency, Glutaryl-CoA oxidase deficiency |
| RS137852862 |
SUGCT
|
Health Risk |
Conflicting classifications of pathogenicity |
Glutaryl-CoA oxidase deficiency, Glutaryl-CoA oxidase deficiency |
| RS137852863 |
NDUFAF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 10 |
| RS137852865 |
HPD
|
Health Risk |
Likely pathogenic |
Tyrosinemia type III, Hawkinsinuria |
| RS137852866 |
HPD
|
Health Risk |
Pathogenic |
Tyrosinemia type III, Tyrosinemia type III |
| RS137852867 |
HPD
|
Health Risk |
Pathogenic |
Tyrosinemia type III, Tyrosinemia type III |
| RS137852868 |
HPD
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinemia type III, Hawkinsinuria |
| RS137852869 |
NDUFA13
|
Health Risk |
Pathogenic |
Hurthle cell carcinoma of thyroid, Hurthle cell carcinoma of thyroid |
| RS137852870 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease type 1A, Maple syrup urine disease |
| RS137852871 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS137852872 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS137852873 |
BCKDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS137852874 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS137852875 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS137852876 |
BCKDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS137852883 |
CLN8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 8, Neuronal ceroid lipofuscinosis 8 |
| RS137852884 |
GNPTG
|
Health Risk |
Pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS137852885 |
GNPTG
|
Health Risk |
Pathogenic/Likely pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS137852886 |
GBE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease IV, nonprogressive hepatic |
| RS137852887 |
GBE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease IV, classic hepatic |
| RS137852888 |
GBE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease IV, classic hepatic |
| RS137852889 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form |
| RS137852890 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form |
| RS137852891 |
GBE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form |
| RS137852892 |
GBE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form |
| RS137852893 |
GBE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form |
| RS137852894 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form |
| RS137852895 |
GNPTAB
|
Health Risk |
Pathogenic |
Pseudo-Hurler polydystrophy, Pseudo-Hurler polydystrophy |
| RS137852896 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS137852897 |
GNPTAB
|
Health Risk |
Pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS137852898 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Mucolipidosis type II |
| RS137852899 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS137852900 |
GNPTAB
|
Health Risk |
Pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS137852901 |
ANTXR2
|
Health Risk |
Pathogenic |
Hyaline fibromatosis syndrome, Hyaline fibromatosis syndrome |
| RS137852902 |
ANTXR2
|
Health Risk |
Pathogenic |
Hyaline fibromatosis syndrome, Hyaline fibromatosis syndrome |
| RS137852903 |
ANTXR2
|
Health Risk |
Pathogenic |
Hyaline fibromatosis syndrome, Hyaline fibromatosis syndrome |
| RS137852904 |
ANTXR2
|
Health Risk |
Pathogenic |
Hyaline fibromatosis syndrome, Hyaline fibromatosis syndrome |
| RS137852905 |
ANTXR2
|
Health Risk |
Pathogenic |
Hyaline fibromatosis syndrome, Hyaline fibromatosis syndrome |
| RS137852906 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia 1 |
| RS137852907 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia 1, Glanzmann thrombasthenia |
| RS137852908 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia 1 |
| RS137852910 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia 1, Glanzmann thrombasthenia |
| RS137852911 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia 1 |
| RS137852912 |
PCSK9
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercholesterolemia, autosomal dominant |
| RS137852913 |
MCFD2
|
Health Risk |
Pathogenic |
Factor 5 and Factor VIII, combined deficiency of |
| RS137852914 |
MCFD2
|
Health Risk |
Pathogenic |
Factor 5 and Factor VIII, combined deficiency of |
| RS137852915 |
EPM2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive myoclonic epilepsy, Myoclonic epilepsy of Lafora 1 |
| RS137852916 |
EPM2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Lafora disease, Progressive myoclonic epilepsy |
| RS137852917 |
EPM2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive myoclonic epilepsy, Myoclonic epilepsy of Lafora 1 |
| RS137852918 |
NPHP4
|
Health Risk |
Pathogenic |
Nephronophthisis 4, Nephronophthisis |
| RS137852919 |
NPHP4
|
Health Risk |
Pathogenic |
Nephronophthisis 4, Nephronophthisis |
| RS137852920 |
NPHP4
|
Health Risk |
Pathogenic |
Nephronophthisis 4, Cerebello-oculo-renal syndrome (nephronophthisis |
| RS137852922 |
NPHP4
|
Health Risk |
Pathogenic |
Senior-Loken syndrome 4, Nephronophthisis |
| RS137852923 |
NPHP4
|
Health Risk |
Pathogenic |
Senior-Loken syndrome 4, Nephronophthisis |
| RS137852924 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS137852925 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS137852926 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS137852927 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS137852929 |
FLCN
|
Health Risk |
Pathogenic/Likely pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS137852930 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS137852931 |
ST14
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 11, Autosomal recessive congenital ichthyosis 11 |
| RS137852932 |
ST14
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 11, Autosomal recessive congenital ichthyosis 11 |
| RS137852934 |
PRODH
|
Health Risk |
Conflicting classifications of pathogenicity |
Proline dehydrogenase deficiency, Schizophrenia 4 |
| RS137852937 |
ALDH4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperprolinemia type 2, Hyperprolinemia type 2 |
| RS137852944 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Colorectal cancer |
| RS137852946 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS137852947 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS137852948 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Inborn genetic diseases |
| RS137852949 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal dominant polycystic liver disease |
| RS137852950 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS137852951 |
TLL1
|
Health Risk |
Pathogenic |
Atrial septal defect 6, Atrial septal defect 6 |
| RS137852953 |
TLL1
|
Health Risk |
Pathogenic |
Atrial septal defect 6, Atrial septal defect 6 |
| RS137852955 |
TBX20
|
Health Risk |
Pathogenic |
Atrial septal defect 4, Atrial septal defect 4 |
| RS137852956 |
TWNK
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3 |
| RS137852957 |
SLC19A3
|
Health Risk |
Pathogenic |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS137852958 |
SLC19A3
|
Health Risk |
Pathogenic |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS137852959 |
PANK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pigmentary pallidal degeneration, Hypoprebetalipoproteinemia |
| RS137852960 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS137852961 |
PANK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS137852962 |
PANK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS137852963 |
PANK2
|
Health Risk |
Likely pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS137852964 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS137852965 |
PANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS137852967 |
PANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pigmentary pallidal degeneration, Hypoprebetalipoproteinemia |
| RS137852968 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Dystonic disorder |
| RS137852969 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS137852970 |
BSCL2
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy type 2, Inborn genetic diseases |
| RS137852971 |
BSCL2
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy type 2, Charcot-Marie-Tooth disease type 2 |
| RS137852972 |
BSCL2;HNRNPUL2-BSCL2
|
Health Risk |
Pathogenic |
Neuronopathy, distal hereditary motor |
| RS137852973 |
BSCL2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 17, Charcot-Marie-Tooth disease type 2 |
| RS137852974 |
BSCL2
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy type 2, Berardinelli-Seip congenital lipodystrophy |
| RS137852975 |
BSCL2
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy type 2, Charcot-Marie-Tooth disease type 2 |
| RS137852976 |
DICER1
|
Health Risk |
Likely pathogenic |
Pleuropulmonary blastoma, DICER1-related tumor predisposition |
| RS137852977 |
DICER1
|
Health Risk |
Pathogenic |
Pleuropulmonary blastoma, Hereditary cancer-predisposing syndrome |